World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
79
Citations
28503
World Ranking
17413
National Ranking
199

Overview

Winnie Yeo is a researcher affiliated with the Chinese University of Hong Kong in China, specializing primarily in the field of Medicine with a focus on Oncology. Their research output covers a broad range of topics related to cancer treatment, survivorship, and pharmacology, with a significant emphasis on breast cancer and associated therapies.

Their key research topics include:

  • Breast Cancer Treatment Studies
  • Cancer Risks and Factors
  • Advanced Breast Cancer Therapies
  • Nausea and vomiting management
  • HER2/EGFR in Cancer Research
  • Cancer Treatment and Pharmacology
  • Cancer survivorship and care

Winnie Yeo has published extensively in several academic venues, frequently contributing to journals such as:

  • Cancer Research
  • Journal of Clinical Oncology
  • Annals of Oncology
  • Research Square (Research Square)
  • Hong Kong Medical Journal

Among their recent publications are:

  • "Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial," 2022, The Lancet
  • "HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer: an international multicentre cohort study and TCGA-METABRIC analysis," 2022, BMC Medicine
  • "BEGONIA: Phase 1b/2 study of durvalumab (D) combinations in locally advanced/metastatic triple-negative breast cancer (TNBC)-Initial results from arm 1, d+paclitaxel (P), and arm 6, d+trastuzumab deruxtecan (T-DXd)," 2021, Journal of Clinical Oncology
  • "Nivolumab in sorafenib-naive and sorafenib-experienced patients with advanced hepatocellular carcinoma: 5-year follow-up from CheckMate 040," 2023, Annals of Oncology
  • "Antiobesity effect of ethanolic extract of Ramulus mori in differentiated 3T3-L1 adipocytes and high-fat diet-induced obese mice," 2020, Journal of Ethnopharmacology

Frequent collaborators in their research include:

  • Frankie Mo
  • Seock-Ah Im
  • Suzanne C. Ho
  • Carol Kwok
  • Ashley Cheng

Winnie Yeo's subfields of study illustrate a diverse engagement with medical sciences, primarily through:

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research
  • Surgery
  • Physiology

Best Publications

  • Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial

    Anthony B. El-Khoueiry;Bruno Sangro;Thomas Yau;Todd S. Crocenzi

  • Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade

    Philip J. Johnson;Sarah Berhane;Chiaki Kagebayashi;Shinji Satomura

  • Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors

    Winnie Yeo;Paul K.S. Chan;Sheng Zhong;Wing M. Ho

  • Hepatitis B Virus Reactivation in Lymphoma Patients With Prior Resolved Hepatitis B Undergoing Anticancer Therapy With or Without Rituximab

    Winnie Yeo;Tung C. Chan;Nancy W.Y. Leung;Wai Y. Lam

  • A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma.

    Winnie Yeo;Tony S. Mok;Benny Zee;Thomas W. T. Leung

  • Overall Survival After Concurrent Cisplatin-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma

    Anthony Tak-cheung Chan;Sing-fai Leung;Roger K.C. Ngan;Peter M.L. Teo

  • Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

    Sandra M Swain;Sandra M Swain;David Miles;Sung-Bae Kim;Young-Hyuck Im

  • Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy†

    Winnie Yeo;Philip J. Johnson

  • Concurrent Chemotherapy-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma: Progression-Free Survival Analysis of a Phase III Randomized Trial

    A.T.C. Chan;P.M.L. Teo;R.K. Ngan;T.W. Leung

  • Adjuvant intra-arterial lipiodol-iodine-131 for resectable hepatocellular carcinoma: a prospective randomised trial

    W. Y. Lau;T. W.T. Leung;S. K.W. Ho;M. Chan

  • Clinical Scoring System to Predict Hepatocellular Carcinoma in Chronic Hepatitis B Carriers

    Vincent Wai Sun Wong;Stephen Lam Chan;Frankie Mo;Tung Ching Chan

  • Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy.

    Winnie Yeo;Benny Chung-ying Zee;S. Zhong;P. K.S. Chan

  • A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma.

    Anthony T.C. Chan;Peter M.L. Teo;Thomas W.T. Leung;Sing F. Leung

  • Complete Pathological Remission Is Possible with Systemic Combination Chemotherapy for Inoperable Hepatocellular Carcinoma

    Thomas W.T. Leung;Yehuda Z. Patt;Wan Yee Lau;Stephen K.W. Ho

  • High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma.

    Henry Lik Yuen Chan;Chi Hang Tse;Frankie Mo;Jane Koh

  • Lamivudine for the Prevention of Hepatitis B Virus Reactivation in Hepatitis B s-Antigen Seropositive Cancer Patients Undergoing Cytotoxic Chemotherapy

    Winnie Yeo;Paul K.S. Chan;Wing M. Ho;Benny Zee

  • New Utility of an Old Marker: Serial α-Fetoprotein Measurement in Predicting Radiologic Response and Survival of Patients With Hepatocellular Carcinoma Undergoing Systemic Chemotherapy

    Stephen L. Chan;Frankie K.F. Mo;Philip J. Johnson;Edwin P. Hui

  • Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients

    Sarah Berhane;Hidenori Toyoda;Toshifumi Tada;Takashi Kumada

  • Frequent p15 Promoter Methylation in Tumor and Peripheral Blood from Hepatocellular Carcinoma Patients

    I. H.N. Wong;Yuk-ming Dennis Lo;Winnie Yeo;W. Y. Lau

  • Phase I/II safety and antitumor activity of nivolumab in patients with advanced hepatocellular carcinoma (HCC): CA209-040.

    Anthony B. El-Khoueiry;Ignacio Melero;Todd S. Crocenzi;Theodore Hobart Welling

Frequent Co-Authors

Anthony T.C. Chan
Anthony T.C. Chan Chinese University of Hong Kong
Stephen L. Chan
Stephen L. Chan Chinese University of Hong Kong
Philip J. Johnson
Philip J. Johnson University of Liverpool
Tony Mok
Tony Mok Chinese University of Hong Kong
Paul B.S. Lai
Paul B.S. Lai Chinese University of Hong Kong
Paul K.S. Chan
Paul K.S. Chan Chinese University of Hong Kong
Bruno Sangro
Bruno Sangro University of Navarra
Benny Chung-ying Zee
Benny Chung-ying Zee Chinese University of Hong Kong
Masatoshi Kudo
Masatoshi Kudo Kindai University
Anthony W.H. Chan
Anthony W.H. Chan Chinese University of Hong Kong

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine opens the door to many online degree options that can advance your education and professional growth. If you’re considering leadership roles within healthcare, understanding the cost of mha degree programs is essential. Affordability and financial planning are key factors when choosing a path in healthcare administration.

For registered nurses aiming for the highest level of clinical practice, the best online bsn to dnp programs offer advanced, flexible ways to reach a Doctor of Nursing Practice degree. Similarly, pharmacists can expand their scope with online pharmd programs that emphasize both affordability and convenience.

Beyond clinical roles, the growing field of health data offers new opportunities. Earning a health information management bachelor degree online can pave the way for in-demand roles in healthcare systems, insurance, and data analysis. Each pathway comes with its own admission requirements, costs, and career possibilities—making it vital to research and select the online program that aligns best with your goals.

Best Scientists Citing Winnie Yeo

Trending Scientists